{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:29:19Z","timestamp":1783351759728,"version":"3.54.6"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1097\/iop.0000000000000053","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T10:23:12Z","timestamp":1391077392000},"page":"219-224","source":"Crossref","is-referenced-by-count":18,"title":["Eighteen-Point Abobotulinum Toxin A Upper Face Rejuvenation"],"prefix":"10.1097","volume":"30","author":[{"given":"Mohsen Bahmani","family":"Kashkouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansooreh","family":"Jamshidian-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis Alsadat","family":"Jazayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210129","first-page":"1081","article-title":"Retrospective review of 500 patients treated with abobotulinumtoxinA.","volume":"9","author":"Hevia","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.","volume":"53","author":"Cote","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaad.2003.11.084","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.","volume":"51","author":"Ascher","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0974-2077.99451","article-title":"Complications of minimally invasive cosmetic procedures: prevention and management.","volume":"5","author":"Levy","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"142e","DOI":"10.1097\/PRS.0b013e3182362c63","article-title":"Cosmetic medicine: facial resurfacing and injectables.","volume":"129","author":"Nguyen","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mjd.2001.118342","article-title":"Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases.","volume":"46","author":"Alam","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1524-4725.1996.tb00345.x","article-title":"The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions.","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00266-004-0031-7","article-title":"Complications with the use of botulinum toxin type a in facial rejuvenation: report of 8 cases.","volume":"28","author":"Ferreira","year":"2004","journal-title":"Aesthetic Plast Surg"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/IOP.0b013e31802dfca7","article-title":"Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.","volume":"23","author":"Arat","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5021\/ad.2011.23.2.217","article-title":"Exaggeration of wrinkles after botulinum toxin injection for forehead horizontal lines.","volume":"23","author":"Kang","year":"2011","journal-title":"Ann Dermatol"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/01.PRS.0000097307.62862.27","article-title":"Role of new fillers in facial rejuvenation: a cautious outlook.","volume":"112","author":"Rohrich","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/SAP.0b013e31812f6e0f","article-title":"EMLA cream application without occlusive dressing before upper facial botulinum toxin injection: a randomized, double-blind, placebo-controlled trial.","volume":"60","author":"Kashkouli","year":"2008","journal-title":"Ann Plast Surg"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/09546634.2013.789473","article-title":"Adverse events associated with botulinum toxin injection: A multidepartment, retrospective study of 5310 treatments administered to 1819 subjects.","volume":"25","author":"Kim","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1473-2165.2007.00325.x","article-title":"Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.","volume":"6","author":"Farahvash","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"R20-5-20210129","first-page":"72","article-title":"Botulinum toxin A in aesthetic dermatology.","volume":"24","author":"Rzany","year":"2003","journal-title":"Kosmet Med"},{"key":"R21-5-20210129","first-page":"34","article-title":"Second expert meeting on the use of botulinum toxin A (Dysport) in aesthetic dermatology.","volume":"3","author":"Rzany","year":"2005","journal-title":"Kosmet Med"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.asj.2005.05.004","article-title":"Botulinum toxin A in the treatment of glabellar lines: scheduling the next injection.","volume":"25","author":"Ascher","year":"2005","journal-title":"Aesthet Surg J"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870090106","article-title":"Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.","volume":"9","author":"Borodic","year":"1994","journal-title":"Mov Disord"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1524-4725.1996.tb00569.x","article-title":"Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study.","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1067\/mjd.2002.124070","article-title":"Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crows feet.","volume":"47","author":"Lowe","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"BOTOX Glabellar Lines I Study Group. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.","volume":"46","author":"Carruthers","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1524-4725.1996.tb00569.x","article-title":"Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study.","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.136.4.539","article-title":"Botulinum toxin: beyond cosmesis.","volume":"136","author":"Klein","year":"2000","journal-title":"Arch Dermatol"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/sder.2001.25964","article-title":"Complications and adverse reactions with the use of botulinum toxin.","volume":"20","author":"Klein","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0301-4738.90496","article-title":"Transient superior oblique paresis after injection of Botulinum Toxin A for facial rejuvenation.","volume":"60","author":"Kothari","year":"2012","journal-title":"Indian J Ophthalmol"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0000000000000053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:13:49Z","timestamp":1620954829000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-201405000-00005"}},"subtitle":["An Eye Plastic Perspective on 845 Subjects"],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0000000000000053","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}